Cutting edge Seminar

 

Speaker: Mikiko Y Takeda, Ph.D. (Assistant Professor, Pharmacy Practice & Administrative Sciences, college of Pharmacy, The University of New Mexico)

Title: Co-prescription of Naloxone as a Universal Precautions Model for Patients on Chronic Opioid Therapy – Observational Study

 

Date&Time:  25 Oct. (Tue.) 2016, 12:00- 13:00
Venue: Conference Room(1F), IMEG

Abstract: The epidemic of lethal prescription opioid overdose is one of the most pressing public health problems in the United States. In an ambulatory clinic setting, current practice guidelines suggest healthcare providers should screen patient’s aberrant drug-related behaviors. Given the difficulty of predicting which patients on chronic opioid therapy (COT) will experience opioid overdose, a new paradigm of harm reduction is called for. In previous studies, naloxone, an opioid antagonist, was given only to high risk patients. However, if naloxone is co-prescribed in a Universal Precautions manner for all patients receiving COT, this may have a significant impact on intentional and unintentional opioid overdose deaths.

 

Reference:

Takeda MY, Katzman JG, Dole E, Bennett MH, Alchbli A, Duhigg D, Yonas H. Subst Abus. 2016 Apr 19:0. PMID: 27093555

 

Click here for the details